JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218268

HIV1 p24 ELISA试剂盒

HIV1 p24 ELISA Kit

Be the first to review this product! Submit a review

|

(22 Publications)

HIV1 p24 ELISA kit is a single-wash 90-min SimpleStep ELISA® used to quantify HIV-1 p24 antigen with a sensitivity of 1.1 pg/mL. The assay uses a simple Mix-Wash-Read protocol with just one incubation and wash step.

- Colorimetric sandwich ELISA - 450nm readout; works on any plate reader
- Used for the quantification of lentivirus titer in cell therapy applications
- Broad sample compatibility – works with cell culture extracts, tissue extracts, cell culture supernatants, serum, and plasma
- Cited in over 20 publications

查看别名

Gag-Pol polyprotein, Pr160Gag-Pol, gag-pol

15 Images
Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Lab

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Interpolated concentrations of spike HIV1 p24 in Jurkat Cell Extract and RPMI + 10% FBS cell culture media.

The concentrations of HIV1 p24 were measured in duplicates, interpolated from the HIV1 p24 standard curves and corrected for sample dilution. Undiluted samples are as follows : Jurkat cell extract 100 μg/mL, RPMI + 10% FBS cell culture media 100% (neat). The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2).

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Unknown

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Acid treatment recovery of synthetic complexes.

Single concentrations of purified HIV-1 p24 protein were spiked to the indicated biological matrix, pre-incubated with unlabeled capture and detector antibodies or unrelated antibodies and treated with the Acid Treatment Protocol to evaluate the signal recovery of p24 complexed with interfering antibodies by Acid Treatment Protocol. The signals of single concentrations of purified HIV-1 p24 protein spiked to the indicated biological matrix, preincubated with unrelated antibodies and treated with the Acid Treatment Protocol were taken as 100%. There were no signals if the single concentrations of purified HIV-1 p24 protein were spiked to the indicated biological matrix, pre-incubated with the unlabeled capture and detector antibodies and mock acid treated, indicating that the unlabeled capture and detector antibodies efficiently formed synthetic immune complexes with HIV-1 p24 and completely blocked the signals.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Unknown

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Acid treatment effect.

Single concentrations of purified HIV-1 p24 protein were spiked in duplicate to the indicated biological matrix and treated with the Acid Treatment Protocol or mock acid treated to evaluate the effect of the Acid Treatment Protocol on the signal. The signals of single concentrations of purified HIV-1 p24 protein spiked in duplicate to the indicated biological matrix and mock acid treated were taken as 100%.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Unknown

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Acid treatment recovery.

Three concentrations of purified HIV-1 p24 protein were spiked in duplicate to the indicated biological matrix and treated with the Acid Treatment Protocol to evaluate signal recovery in the working range of the assay. The signals of the same concentrations of purified HIV-1 p24 protein spiked in duplicate to Sample Diluent 50BS and treated with the Acid Treatment Protocol were taken as 100%.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Interpolated concentrations of spike HIV1 p24 in human serum, human plasmas, and rhesus macaque plasma.

The concentrations of HIV1 p24 were measured in duplicates, interpolated from the HIV1 p24 standard curves and corrected for sample dilution. Undiluted samples are as follows : human serum 100% (neat), human plasma (heparin) 100% (neat), human plasma (EDTA) 100% (neat), and rhesus macaque plasma (EDTA) 100% (neat). The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2).

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Serial dilutions of recombinant HIV1 p24 were prepared within the working range of the assay and assayed for reactivity.

Serial dilutions of recombinant HIV1 p24 (group M, subtype B, strain 92418), HIV1 p24 (group M, subtype C, strain 92BR025) and HIV1 p24 (group O, strain BCF06) were prepared within the working range of the assay and assayed for reactivity. O.D. values within the linear range of each protein are graphed.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Unknown

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Linearity of dilution – spiked purified HIV-1 p24 in FBS cell culture media and Jurkat Cell Extract.

Purified HIV-1 p24 was spiked into biological samples and diluted in a 2-fold dilution series in Sample Diluent NS for cell culture media and 1X Cell Extraction Buffer PTR for cell extract samples.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Unknown

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Linearity of dilution – spiked Purified HIV-1 p24 in Human serum, plasma (heparin, citrate, EDTA) and rhesus macaque EDTA plasma.

Purified HIV-1 p24 was spiked into biological samples and diluted in a 2-fold dilution series in Sample Diluent 50BS.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Example of HIV1 p24 standard curve in Sample Diluent 50BS.

Background-subtracted data values (mean +/- SD) are graphed.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Example of HIV-1 p24 standard curve in 1X Cell Extraction Buffer PTR.

Raw data values are shown in the table

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Raw data values for example of HIV-1 p24 standard curve in Sample Diluent NS.

Raw data values are shown in the table

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Example of HIV1 p24 standard curve in Sample Diluent NS.

Background-subtracted data values (mean +/- SD) are graphed.

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Raw data values for Example of HIV-1 p24 standard curve in Sample Diluent 50BS.

Raw data values are shown in the table

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)
  • sELISA

Supplier Data

Sandwich ELISA - HIV1 p24 ELISA Kit (AB218268)

Example of HIV1 p24 standard curve in 1X Cell Extraction Buffer PTR.

Background-subtracted data values (mean +/- SD) are graphed.

关键信息

检测方法

Colorimetric

样品类型

Cell culture extracts, Tissue Extracts, Heparin Plasma, Cell culture supernatant, Serum, EDTA Plasma

反应种属

Human

检测类型

Sandwich (quantitative)

灵敏度

= 1.1 pg/mL

范围

4.69 - 300 pg/mL

检测时间

1h 30m

检测平台

Pre-coated microplate (12 x 8 well strips)

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

产品详情

HIV1 p24 ELISA Kit ab218268 is a rapid single-wash 90-min ELISA kit to measure HIV1 p24 in cell culture extracts, tissue extracts, serum and plasma. This SimpleStep ELISA® sensitivity is 1.1 pg/mL.

How the assay works

HIV1 p24 SimpleStep ELISA® employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details.

Assay Specificity

Our HIV1 p24 SimpleStep ELISA® can be used to rapidly and sensitively determine the titre of HIV1 particles in range of sample types.

HIV1 p24 ELISA Kit ab218268 protocol summary:

1. Mix: add samples/standards to the wells together with the capture and detector antibody cocktail. Incubate for 1 hr at room temperature
2. Wash
3. Add TMB development solution - incubate for 10 min
4. Add stop solution
5. Read the results on a plate reader at 450nm

How other researchers are using HIV1 p24 ELISA Kit ab218268:

HIV1 p24 ELISA Kit ab218268 has been used in publications to study HIV-1 infection and therapeutic approaches to AIDS (1)(2)

References:

(1)Kai Deng et al. 2021 PMID: 33835029,
(2)Vir B Singh et al. 2023 PMID: 37663574

Related and recommended products

HIV1 p24 ELISA Kit ab218268 is commonly used to study lentivirus vectors based on HIV-1.

Other products for analyzing lentiviruses include:

- Mounting Medium with DAPI - Aqueos, Fluoroshield ab104139
- Goat Anti-Mouse IgG H&L (HRP) ab205719

HIV1 p24 (capsid) protein is essential for HIV-1 viral replication and for the HIV-1 infection of non-dividing cells. HIV1 p24 proteins form viral capsid that encapsulates the genomic HIV1 RNA. HIV1 p24 concentration in host plasma is commonly used as indicator of viral load. Upon the viral infection, the development of anti-HIV1 p24 host humoral responses leads to immune complex formation and reduction of the free HIV1 p24 concentration in circulation.

Lentivirus vectors based on HIV-1 have gained popularity as a tool for cell and gene therapy, owing to their ability to carry and integrate a high volume of transgenes in a range of dividing and non-dividing cell types. Pseudo-lentiviral particles are typically produced from 293T cells and harvested from the medium 48-78hrs post-transfection. To ensure that the pseudoviral medium is viable, and to control the number of copies of integrated viral constructs per target cell, the viral titre needs to be determined before transduction experiments. Our HIV1 p24 SimpleStep ELISA® can be used to rapidly and sensitively determine the titre of HIV1 particles in range of sample types.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

精确度

[ { "reproducibilityType": "Inter", "sample": "Overall", "replicates": 5, "mean": null, "standardDeviation": null, "coefficientOfVariability": "4.7" }, { "reproducibilityType": "Intra", "sample": "Overall", "replicates": 3, "mean": null, "standardDeviation": null, "coefficientOfVariability": "4.5" } ]

回收率

[ { "sample": "Serum", "range": "94 - 117 %", "average": "= 105" }, { "sample": "EDTA Plasma", "range": "93 - 103 %", "average": "= 98" }, { "sample": "Cell culture extracts", "range": "103 - 113 %", "average": "= 107" }, { "sample": "Heparin Plasma", "range": "100 - 103 %", "average": "= 102" }, { "sample": "Cell culture media", "range": "94 - 107 %", "average": "= 102" } ]

规格

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab218268-1x96Tests", "assetComponentDetails": [ { "size":"1 x 12 mL", "name":"Stop Solution", "number":"AB218268-CMP07", "productcode":"" }, { "size":"1 x 1 mL", "name":"50X Cell Extraction Enhancer Solution (ab193971)", "number":"AB218268-CMP13", "productcode":"" }, { "size":"1 x 20 mL", "name":"10X Wash Buffer PT (ab206977)", "number":"AB218268-CMP12", "productcode":"" }, { "size":"1 x 50 mL", "name":"Sample Diluent NS (ab193972)", "number":"AB218268-CMP05", "productcode":"" }, { "size":"1 x 12 mL", "name":"TMB Development Solution", "number":"AB218268-CMP09", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Plate Seals", "number":"AB218268-CMP11", "productcode":"" }, { "size":"1 x 6 mL", "name":"Antibody Diluent 5BI", "number":"AB218268-CMP03", "productcode":"" }, { "size":"1 x 600 µL", "name":"10X HIV1 p24 Capture Antibody", "number":"AB218268-CMP01", "productcode":"" }, { "size":"2 x 1 Vial", "name":"HIV1 p24 Lyophilized Recombinant Protein", "number":"AB218268-CMP08", "productcode":"" }, { "size":"1 x 20 mL", "name":"Sample Diluent 50BS", "number":"AB218268-CMP04", "productcode":"" }, { "size":"1 x 600 µL", "name":"10X HIV1 p24 Detector Antibody", "number":"AB218268-CMP02", "productcode":"" }, { "size":"1 x 1 Unit", "name":"SimpleStep Pre-Coated 96-Well Microplate (ab206978)", "number":"AB218268-CMP06", "productcode":"" }, { "size":"1 x 10 mL", "name":"5X Cell Extraction Buffer PTR (ab193970)", "number":"AB218268-CMP10", "productcode":"" } ] } } }

性能和储存信息

运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C
储存信息
+4°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The p24 protein also known as the HIV-1 capsid protein or CA is an important component of the Human Immunodeficiency Virus Type 1 (HIV-1). It has a molecular weight of approximately 24 kDa. This protein is expressed in the viral core and plays a critical role in the virus's structural integrity. The p24 protein helps form the conical core that encases the viral RNA genome. Antibody-based detection of this protein is a common approach to study HIV often utilizing tools such as the p24 ELISA kit and p24 assay which are pivotal in early HIV detection and research.
Biological function summary

The p24 protein is essential in the assembly and maturation of the HIV-1 virion. It forms part of the Gag polyprotein precursor which undergoes proteolytic cleavage to create the mature viral proteins necessary for the formation of infectious particles. The Gag polyprotein assembles into the immature virion and later cleaves into functional units including the matrix capsid and nucleocapsid proteins. This process ensures the viral core is capable of delivering the genetic material to the host cell during infection. Such assembly is important for maintaining the infective efficiency of the HIV-1 virus.

Pathways

P24 plays an integral role in the lifecycle of HIV-1 especially in the virus replication and assembly pathways. It interacts with host cellular machinery to facilitate the viral assembly and is involved in the highly coordinated regulation of the viral life cycle. This protein shares pathway connections with other viral proteins such as p55 Gag and matrix protein p17 both of which also derive from the Gag polyprotein. These interactions underline the importance of p24 in the broader context of HIV-1's ability to propagate within host cells.

The p24 protein is directly linked to the pathogenesis of Acquired Immunodeficiency Syndrome (AIDS). Understanding and detecting the presence of p24 are vital for diagnosing and monitoring the progression of HIV-1 infection. Additionally it holds a significant relationship with immune system disorders due to the virus's effect on immune function. p24 detection is often a component in HIV ELISA and HIV p24 ELISA tests which measure the presence of the virus in the bloodstream. The protein also connects to the envelope glycoprotein gp120 which is involved in initial host cell binding and viral entry furthering its pivotal role in the progression of HIV-related diseases.

产品实验方案

靶点信息

Gag-Pol polyprotein. Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi). Gag-Pol polyprotein may regulate its own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, the polyprotein would promote translation, whereas at high concentration, the polyprotein would encapsidate genomic RNA and then shut off translation.. Matrix protein p17. Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus (By similarity). Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA (By similarity).. Capsid protein p24. Forms the conical core that encapsulates the genomic RNA-nucleocapsid complex in the virion (PubMed : 8648689). Most core are conical, with only 7% tubular. The core is constituted by capsid protein hexamer subunits. The core is disassembled soon after virion entry (PubMed : 12660176). Host restriction factors such as monkey TRIM5-alpha or TRIMCyp bind retroviral capsids and cause premature capsid disassembly, leading to blocks in reverse transcription. Capsid restriction by TRIM5 is one of the factors which restricts HIV-1 to the human species (PubMed : 23785198). Host PIN1 apparently facilitates the virion uncoating (By similarity). On the other hand, interactions with PDZD8 or CYPA stabilize the capsid (PubMed : 24554657).. Nucleocapsid protein p7. Encapsulates and protects viral dimeric unspliced genomic RNA (gRNA). Binds these RNAs through its zinc fingers. Acts as a nucleic acid chaperone which is involved in rearangement of nucleic acid secondary structure during gRNA retrotranscription. Also facilitates template switch leading to recombination. As part of the polyprotein, participates in gRNA dimerization, packaging, tRNA incorporation and virion assembly.. Protease. Aspartyl protease that mediates proteolytic cleavages of Gag and Gag-Pol polyproteins during or shortly after the release of the virion from the plasma membrane (PubMed : 11932404, PubMed : 9573231). Cleavages take place as an ordered, step-wise cascade to yield mature proteins (PubMed : 11932404, PubMed : 9573231). This process is called maturation (PubMed : 11932404, PubMed : 9573231). Displays maximal activity during the budding process just prior to particle release from the cell (PubMed : 11932404, PubMed : 9573231). Also cleaves Nef and Vif, probably concomitantly with viral structural proteins on maturation of virus particles (PubMed : 7835426). Hydrolyzes host EIF4GI and PABP1 in order to shut off the capped cellular mRNA translation. The resulting inhibition of cellular protein synthesis serves to ensure maximal viral gene expression and to evade host immune response (PubMed : 12660176, PubMed : 19914170). Also mediates cleavage of host YTHDF3 (PubMed : 32053707). Mediates cleavage of host CARD8, thereby activating the CARD8 inflammasome, leading to the clearance of latent HIV-1 in patient CD4(+) T-cells after viral reactivation; in contrast, HIV-1 can evade CARD8-sensing when its protease remains inactive in infected cells prior to viral budding (PubMed : 33542150).. Reverse transcriptase/ribonuclease H. Multifunctional enzyme that converts the viral RNA genome into dsDNA in the cytoplasm, shortly after virus entry into the cell. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3' to 5' endonucleasic mode. Conversion of viral genomic RNA into dsDNA requires many steps. A tRNA(3)-Lys binds to the primer-binding site (PBS) situated at the 5'-end of the viral RNA. RT uses the 3' end of the tRNA primer to perform a short round of RNA-dependent minus-strand DNA synthesis. The reading proceeds through the U5 region and ends after the repeated (R) region which is present at both ends of viral RNA. The portion of the RNA-DNA heteroduplex is digested by the RNase H, resulting in a ssDNA product attached to the tRNA primer. This ssDNA/tRNA hybridizes with the identical R region situated at the 3' end of viral RNA. This template exchange, known as minus-strand DNA strong stop transfer, can be either intra- or intermolecular. RT uses the 3' end of this newly synthesized short ssDNA to perform the RNA-dependent minus-strand DNA synthesis of the whole template. RNase H digests the RNA template except for two polypurine tracts (PPTs) situated at the 5'-end and near the center of the genome. It is not clear if both polymerase and RNase H activities are simultaneous. RNase H probably can proceed both in a polymerase-dependent (RNA cut into small fragments by the same RT performing DNA synthesis) and a polymerase-independent mode (cleavage of remaining RNA fragments by free RTs). Secondly, RT performs DNA-directed plus-strand DNA synthesis using the PPTs that have not been removed by RNase H as primers. PPTs and tRNA primers are then removed by RNase H. The 3' and 5' ssDNA PBS regions hybridize to form a circular dsDNA intermediate. Strand displacement synthesis by RT to the PBS and PPT ends produces a blunt ended, linear dsDNA copy of the viral genome that includes long terminal repeats (LTRs) at both ends.. Integrase. Catalyzes viral DNA integration into the host chromosome, by performing a series of DNA cutting and joining reactions. This enzyme activity takes place after virion entry into a cell and reverse transcription of the RNA genome in dsDNA. The first step in the integration process is 3' processing. This step requires a complex comprising the viral genome, matrix protein, Vpr and integrase. This complex is called the pre-integration complex (PIC). The integrase protein removes 2 nucleotides from each 3' end of the viral DNA, leaving recessed CA OH's at the 3' ends. In the second step, the PIC enters cell nucleus. This process is mediated through integrase and Vpr proteins, and allows the virus to infect a non dividing cell. This ability to enter the nucleus is specific of lentiviruses, other retroviruses cannot and rely on cell division to access cell chromosomes. In the third step, termed strand transfer, the integrase protein joins the previously processed 3' ends to the 5' ends of strands of target cellular DNA at the site of integration. The 5'-ends are produced by integrase-catalyzed staggered cuts, 5 bp apart. A Y-shaped, gapped, recombination intermediate results, with the 5'-ends of the viral DNA strands and the 3' ends of target DNA strands remaining unjoined, flanking a gap of 5 bp. The last step is viral DNA integration into host chromosome. This involves host DNA repair synthesis in which the 5 bp gaps between the unjoined strands are filled in and then ligated. Since this process occurs at both cuts flanking the HIV genome, a 5 bp duplication of host DNA is produced at the ends of HIV-1 integration. Alternatively, Integrase may catalyze the excision of viral DNA just after strand transfer, this is termed disintegration.
See full target information gag-pol

文献 (22)

Recent publications for all applications. Explore the full list and refine your search

Journal of virus eradication 9:100341 PubMed37663574

2023

Sulforaphane prevents the reactivation of HIV-1 by suppressing NFκB signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Imran Jamal,Anisha Paudel,Landon Thompson,Michel Abdelmalek,Irfan A Khan,Vir B Singh

Cell reports 42:112271 PubMed36995936

2023

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses.

Applications

Unspecified application

Species

Unspecified reactive species

Aiste Dijokaite-Guraliuc,Raksha Das,Daming Zhou,Helen M Ginn,Chang Liu,Helen M E Duyvesteyn,Jiandong Huo,Rungtiwa Nutalai,Piyada Supasa,Muneeswaran Selvaraj,Thushan I de Silva,Megan Plowright,Thomas A H Newman,Hailey Hornsby,Alexander J Mentzer,Donal Skelly,Thomas G Ritter,Nigel Temperton,Paul Klenerman,Eleanor Barnes,Susanna J Dunachie,Cornelius Roemer,Thomas P Peacock,Neil G Paterson,Mark A Williams,David R Hall,Elizabeth E Fry,Juthathip Mongkolsapaya,Jingshan Ren,David I Stuart,Gavin R Screaton

Cell reports 42:111903 PubMed36586406

2023

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.

Applications

Unspecified application

Species

Unspecified reactive species

Jiandong Huo,Aiste Dijokaite-Guraliuc,Chang Liu,Daming Zhou,Helen M Ginn,Raksha Das,Piyada Supasa,Muneeswaran Selvaraj,Rungtiwa Nutalai,Aekkachai Tuekprakhon,Helen M E Duyvesteyn,Alexander J Mentzer,Donal Skelly,Thomas G Ritter,Ali Amini,Sagida Bibi,Sandra Adele,Sile Ann Johnson,Neil G Paterson,Mark A Williams,David R Hall,Megan Plowright,Thomas A H Newman,Hailey Hornsby,Thushan I de Silva,Nigel Temperton,Paul Klenerman,Eleanor Barnes,Susanna J Dunachie,Andrew J Pollard,Teresa Lambe,Philip Goulder,Elizabeth E Fry,Juthathip Mongkolsapaya,Jingshan Ren,David I Stuart,Gavin R Screaton

Molecular therapy. Methods & clinical development 26:157-168 PubMed35846572

2022

Amelioration of experimental tendinopathy by lentiviral CD44 gene therapy targeting senescence-associated secretory phenotypes.

Applications

Unspecified application

Species

Unspecified reactive species

Shih-Yao Chen,I-Ming Jou,Po-Yen Ko,Kai-Lan Hsu,Wei-Ren Su,Li-Chieh Kuo,Pei-Yuan Lee,Chao-Liang Wu,Po-Ting Wu

Cell reports 39:110690 PubMed35417684

2022

Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodeling.

Applications

Unspecified application

Species

Unspecified reactive species

Jeffrey R Johnson,David C Crosby,Judd F Hultquist,Andrew P Kurland,Prithy Adhikary,Donna Li,John Marlett,Justine Swann,Ruth Hüttenhain,Erik Verschueren,Tasha L Johnson,Billy W Newton,Michael Shales,Viviana A Simon,Pedro Beltrao,Alan D Frankel,Alexander Marson,Jeffery S Cox,Oliver I Fregoso,John A T Young,Nevan J Krogan

Cell reports 38:110436 PubMed35235790

2022

Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Anusmita Sahoo,Edgar A Hodge,Celia C LaBranche,Tiffany M Styles,Xiaoying Shen,Narayanaiah Cheedarla,Ayalnesh Shiferaw,Gabriel Ozorowski,Wen-Hsin Lee,Andrew B Ward,Georgia D Tomaras,David C Montefiori,Darrell J Irvine,Kelly K Lee,Rama Rao Amara

Autophagy 18:1256-1273 PubMed34612140

2021

Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hamza Loucif,Xavier Dagenais-Lussier,Daina Avizonis,Luc Choinière,Cherifa Beji,Léna Cassin,Jean-Pierre Routy,Jörg H Fritz,David Olagnier,Julien van Grevenynghe

ACS omega 6:15957-15963 PubMed34179640

2021

HIV Replication Is Increased by RNA Methylation METTL3/METTL14/WTAP Complex Activators.

Applications

Unspecified application

Species

Unspecified reactive species

Simona Selberg,Eva Žusinaite,Koit Herodes,Neinar Seli,Esko Kankuri,Andres Merits,Mati Karelson

Viruses 13: PubMed34069520

2021

Experimental Evaluation of an Interferometric Light Microscopy Particle Counter for Titering and Characterization of Virus Preparations.

Applications

Unspecified application

Species

Unspecified reactive species

Vesa Turkki,Elisa Alppila,Seppo Ylä-Herttuala,Hanna P Lesch

eLife 10: PubMed33835029

2021

Infection with a newly designed dual fluorescent reporter HIV-1 effectively identifies latently infected CD4 T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jinfeng Cai,Hongbo Gao,Jiacong Zhao,Shujing Hu,Xinyu Liang,Yanyan Yang,Zhuanglin Dai,Zhongsi Hong,Kai Deng
View all publications
websiteProtocolBooklet
en

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com